Edge Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-2,207
Closed -$195K 480
2015
Q2
$195K Hold
2,207
0.07% 111
2015
Q1
$196K Hold
2,207
0.07% 101
2014
Q4
$184K Hold
2,207
0.07% 111
2014
Q3
$186K Hold
2,207
0.07% 99
2014
Q2
$179K Buy
2,207
+150
+7% +$11.8K 0.07% 103
2014
Q1
$157K Hold
2,057
0.07% 103
2013
Q4
$148K Hold
2,057
0.07% 100
2013
Q3
$141K Hold
2,057
0.09% 83
2013
Q2
$130K Buy
+2,057
New +$134K 0.09% 77

Other funds holding NVS

Edge Wealth Management's NVS Position: Q3 2015 in Review

Edge Wealth Management sold out of Novartis (NVS) in Q3 2015, closing a stake of 2,207 shares — an estimated $195K sold.

Edge Wealth Management first reported a position in NVS in Q2 2013 and held it in 9 quarters. The position peaked at $196K in Q1 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

  • Edge Wealth Management reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
  • Edge Wealth Management sold 2,207 Novartis shares in Q3 2015, an estimated $195K.
  • Edge Wealth Management first reported a position in Novartis in Q2 2013 and held it in 9 quarters.
  • Edge Wealth Management's Novartis position peaked at $196K in Q1 2015.
  • 926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Edge Wealth Management's 13F filing for Q3 2015, filed 7 Oct 2015.